These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 15373923)

  • 21. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
    Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
    Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression profile of proinflammatory genes in neutrophil-enriched granulocytes stimulated with native anti-PR3 autoantibodies.
    Surmiak M; Kaczor M; Sanak M
    J Physiol Pharmacol; 2012 Jun; 63(3):249-56. PubMed ID: 22791638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-proteinase 3 antibody activation of neutrophils can be inhibited by alpha1-antitrypsin.
    Rooney CP; Taggart C; Coakley R; McElvaney NG; O'Neill SJ
    Am J Respir Cell Mol Biol; 2001 Jun; 24(6):747-54. PubMed ID: 11415941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predominance of IgG1 and IgG3 subclasses of autoantibodies to neutrophil cytoplasmic antigens in patients with systemic lupus erythematosus.
    Manolova I; Dancheva M; Halacheva K
    Rheumatol Int; 2002 Apr; 21(6):227-33. PubMed ID: 12036209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis.
    Hu N; Westra J; Kallenberg CG
    Autoimmun Rev; 2009 May; 8(6):510-4. PubMed ID: 19185066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders.
    Brouwer E; Tervaert JW; Horst G; Huitema MG; van der Giessen M; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1991 Mar; 83(3):379-86. PubMed ID: 1848489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies.
    van Rossum AP; Rarok AA; Huitema MG; Fassina G; Limburg PC; Kallenberg CG
    J Leukoc Biol; 2004 Dec; 76(6):1162-70. PubMed ID: 15331626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
    Hagemo JS; Aasarød K; Moen T
    Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin subclass determines ability of immunoglobulin (Ig)G to capture and activate neutrophils presented as normal human IgG or disease-associated anti-neutrophil cytoplasm antibody (ANCA)-IgG.
    Pankhurst T; Nash G; Williams J; Colman R; Hussain A; Savage C
    Clin Exp Immunol; 2011 May; 164(2):218-26. PubMed ID: 21391987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa.
    Porges AJ; Redecha PB; Kimberly WT; Csernok E; Gross WL; Kimberly RP
    J Immunol; 1994 Aug; 153(3):1271-80. PubMed ID: 8027554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane proteinase 3 expression in patients with Wegener's granulomatosis and in human hematopoietic stem cell-derived neutrophils.
    Schreiber A; Otto B; Ju X; Zenke M; Goebel U; Luft FC; Kettritz R
    J Am Soc Nephrol; 2005 Jul; 16(7):2216-24. PubMed ID: 15901769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subthreshold concentrations of anti-proteinase 3 antibodies (c-ANCA) specifically prime human neutrophils for fMLP-induced leukotriene synthesis and chemotaxis.
    Hattar K; Sibelius U; Bickenbach A; Csernok E; Seeger W; Grimminger F
    J Leukoc Biol; 2001 Jan; 69(1):89-97. PubMed ID: 11200073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
    Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
    Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis.
    Muller Kobold AC; van Wijk RT; Franssen CF; Molema G; Kallenberg CG; Tervaert JW
    Clin Exp Rheumatol; 1999; 17(4):433-40. PubMed ID: 10464553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
    Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
    Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis.
    Holland M; Takada K; Okumoto T; Takahashi N; Kato K; Adu D; Ben-Smith A; Harper L; Savage CO; Jefferis R
    Clin Exp Immunol; 2002 Jul; 129(1):183-90. PubMed ID: 12100039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.
    van der Geld YM; Oost-Kort W; Limburg PC; Specks U; Kallenberg CG
    J Immunol Methods; 2000 Oct; 244(1-2):117-31. PubMed ID: 11033024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.